Lance Clawson
Psychiatry · Bethesda, MDNPI 1114022449
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $821 and has fallen 50.3% since, to $408 in 2025.
Across 160 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$486
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$480
- Tris Pharma Inc$361
- AbbVie$345
- Sunovion Pharmaceuticals Inc.$301
- Takeda Pharmaceuticals U.S.A., Inc.$258
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,13696%
- Education$1214%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$119
- Quillivant$119
- Quillichew ER$119
How this compares
$3,257 in reported general payments places this provider in the 85th percentile of 851 psychiatry providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paliperidone ErPaliperidone | 16 | $15,111 |
| Methylphenidate Hcl Er (Cd)Methylphenidate Hcl | 11 | $7,103 |
| Oxcarbazepine | 37 | $2,833 |
| Lurasidone Hcl | 12 | $2,800 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 17 | $2,687 |
| Divalproex Sodium ErDivalproex Sodium | 13 | $2,181 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 26 | $1,791 |
| Olanzapine | 62 | $1,434 |
| Ziprasidone Hcl | 29 | $1,336 |
| Quetiapine Fumarate | 44 | $1,312 |
| Valproic Acid | 12 | $1,294 |
| Divalproex Sodium | 23 | $1,199 |
| Carbamazepine | 13 | $1,147 |
| Clonazepam | 100 | $976 |
| Risperidone | 54 | $947 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Bethesda
- June CaiBethesda$11K
- Harita RajaBethesda$10K
- Benedetto VitielloBethesda$9K
- John VaethBaltimore$2.1M
- Scott AaronsonBaltimore$334K
- Jamal FawazHagerstown$321K
- Thomas LaughrenRockville$283K
- Adam RothAnnapolis$210K
- Robert LehmanBaltimore$140K
- Karen AndersonBaltimore$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.